Baxter acquiring gene-therapy firm

Share this article:

Almost a week after announcing Baxter was going to break into two divisions, the Illinois company is already expanding.

Crain's Chicago Business reports that the company is buying up partner Chatham Therapeutics for $70 million.

Crain's notes that the $70-million deal may not be an all-in-one payment and that Baxter may provide the gene therapy company milestone payments even after the purchase.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.